Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESONIA nebivolol trial in adolescents with arterial hypertension
2024-518622-32-00Phase 3Completed
- Sponsor
- Medical University of Warsaw
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Medical University of Warsaw. Primary endpoints: Office blood pressure normalization at week 6, Office blood pressure normalization at week 38 and 2 more. Started Jul 2022; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2024-518622-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518622-32-00.